Ligand validation:7AKX

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

OLC is a Ligand Of Interest in 7AKX designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7AKX_OLC_B_307	32%	46%	0.147	0.884	1.14	0.97	1	1	3	0	64%	0.75
7AKX_OLC_A_508	28%	46%	0.153	0.869	1.15	0.93	1	1	3	0	64%	0.75
9IN7_OLC_A_304	33%	80%	0.127	0.869	0.37	0.48	-	-	0	0	64%	1
9IN8_OLC_A_304	24%	86%	0.157	0.852	0.35	0.38	-	-	0	0	64%	1
9IN9_OLC_A_321	13%	92%	0.158	0.753	0.28	0.23	-	-	0	0	68%	1
9F9J_OLC_A_307	100%	42%	0.034	0.981	1.05	1.18	1	2	0	0	100%	1
7YXA_OLC_A_2505	70%	60%	0.127	0.943	0.67	0.84	-	-	3	0	100%	1
9F9D_OLC_A_308	67%	42%	0.081	0.887	0.96	1.29	1	3	0	0	100%	1
7Z0C_OLC_A_803	63%	52%	0.097	0.892	0.82	1.04	1	2	4	0	100%	1
4N6H_OLC_A_1222	63%	56%	0.117	0.932	0.81	0.87	1	1	0	0	88%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.